Vascular Endothelial Growth Factor is implicated in both diabetic retinopathy and wet macular degeneration. Anti-VEGF medications, such as Macugen®, Lucentis® and Avastin® have changed the way we handle both diseases. This week we'll review VEGF and the three key anti-VEGF medications. What is VEGF? Vascular Endothelial Growth Factor (VEGF) is a substance that is produced in the eye. … [Read more...]
SurModics’ Drug Delivery to Release Lucentis for Macular Degeneration
In a press release this week, Surmodics, Inc., announced its agreement with Roche and Genentech, manufactureres of Lucentis® (ranibizumab), to develop a sustained release drug delivery system for the treatment of wet macular degeneration. Surmodics has a drug delivery system based upon biodegradable microparticles that may potentially reduce the annual number injections of Lucentis® a patient … [Read more...]





